WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-02-23

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-23	Common Stock	A	1897.0000	$59.6400	Acquired	63506.9774	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-23	Stock Option (Right to Buy)	$59.6400	A	6504.0000	Acquired	2016-02-23	Common Stock (6504.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	915.4835	Indirect
Common Stock	7361.8265	Indirect

Footnotes

F1: Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.